Skip to main content

/ PharmaMics/ Group items tagged #cancertreatment

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

ESMO 2019: Merck unveils neoadjuvant/adjuvant TNBC trial results - 0 views

www.clinicaltrialsarena.com/...nt-adjuvant-tnbc-trial-results

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #cancertreatment #medicalnews #medicalindustry

shared by ramchintamaneni on 09 Oct 19 - No Cached

ramchintamaneni on 09 Oct 19

At ESMO 2019 Congress, Merck unveiled interim results from pivotal neoadjuvant/adjuvant phase 3 Keynote-522 trial during Presidential Symposium.

<div class="cArrow"> </div><div class="cContentInner">At ESMO 2019 Congress, Merck unveiled interim results from pivotal neoadjuvant/adjuvant phase 3 Keynote-522 trial during Presidential Symposium.</div>

...

Cancel

ESMO 2019: mCRC drug meets endpoints in Pfizer study - 0 views

www.clinicaltrialsarena.com/...crc-drug-meets-endpoint-pfizer

#cancertreatment #esmo2019 #esmocongress #esmoconference #esmocongress2019 #pfizer #mcrc #Colorectalcancer

shared by ramchintamaneni on 22 Oct 19 - No Cached

ramchintamaneni on 22 Oct 19

Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.

<div class="cArrow"> </div><div class="cContentInner">Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.</div>

...

Cancel

Bristol-Myers Squibb: Phase III CheckMate-227, Part 1 study ESMO 2019 - 0 views

www.pharmaceutical-technology.com/...esmo-2019-bristol-myers-squibb

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #bristolmyerssquibb #bms #NSCLC #cancertreatment

shared by ramchintamaneni on 21 Oct 19 - No Cached

ramchintamaneni on 21 Oct 19

Final data from BMS's Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.

<div class="cArrow"> </div><div class="cContentInner">Final data from BMS's Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.</div>

...

Cancel

Lung cancer blood test may replace tumour biopsy - 0 views

www.medicaldevice-network.com/...lung-cancer-blood-test

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #lungcancer #cancertreatment #bloodtest #biopsy

shared by ramchintamaneni on 21 Oct 19 - No Cached

ramchintamaneni on 21 Oct 19

Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options.

<div class="cArrow"> </div><div class="cContentInner">Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options.</div>

...

Cancel

non-small cell lung cancer: AstraZeneca's Tagrisso trial results presented - 0 views

www.clinicaltrialsarena.com/...019-non-small-cell-lung-cancer

#esmo2019 #esmocongress #esmoconference #esmocongress2019 #lungcancer #cancertreatment #nsclc #flaura

shared by ramchintamaneni on 22 Oct 19 - No Cached

ramchintamaneni on 22 Oct 19

Final results from the Phase III FLAURA trial investigating AstraZeneca's Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC.

<div class="cArrow"> </div><div class="cContentInner">Final results from the Phase III FLAURA trial investigating AstraZeneca's Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC.</div>

...

Cancel

1 - 5 of 5

Showing 20▼ items per page

Related searches